Table 8 An assessment of the urinalysis changes affected by the 90-day oral administration of 23%-GNANA, a test substance to the male and female rats (n=10)
Tests** | Result | Severity | Groups (mg/kg/day) |
Male | Female |
G1% | G2 | G3 | G4 | G1 | G2 | G3 | G4 |
0 | 1,250 | 2,500 | 5,000 | 0 | 1,250 | 2,500 | 5,000 |
GLU | - | 0 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
BIL | - | 0 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
KET | - | 0 | 5 | 1 | 4 | 4 | 5 | 5 | 5 | 5 |
+/- | 1 | | 1 | 1 | 1 | | | | |
1+ | 2 | | 3 | | | | | | |
SG | ≤1.005 | 0 | 1 | | | | | | | |
1.010 | 1 | 4 | | | | 4 | 4 | | |
1.015 | 2 | | 1* | 1* | 1* | 1 | | 4* | 3* |
1.020 | 3 | | 3* | 2* | 2* | | 1* | | 1* |
pH | 1.025 | 4 | | 1 | 2 | 2 | | | 1 | |
1.030 | 5 | | | | | | | | 1 |
≤7.0 | 1 | | 1 | | | | | | |
7.5 | 2 | 2 | 2 | 3 | 4 | 1 | 1 | 2 | 1 |
8.0 | 3 | 3 | 2 | 1 | 1 | 1 | 2 | 3 | 3 |
PRO | 8.5 | 4 | | | 1* | | 3 | 2 | | 1 |
- | 0 | 1 | | | | 4 | 2 | 3 | |
+/- | 1 | 3 | | 1 | 1 | 1 | 3* | | 1 |
1+ | 2 | 1 | 3* | | 1 | | | 1* | 3* |
2+ | 3 | | 2* | 3 | 2 | | | 1* | 1* |
UROa) | 3+ | 4 | | | 1 | 1 | | | | |
0.2 | 0 | 5 | 5 | 4 | 5 | 5 | 4 | 4 | 4 |
NIT | 1 | 1 | | | 1 | | | 1 | 1 | 1 |
OB | - | 0 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
- | 0 | 1 | 4 | 4 | 5 | 5 | 5 | 5 | 5 |
+/- | 1 | 3 | 1 | 1 | | | | | |
1+ | 2 | 1 | | | | | | | |
LEU | - | 0 | | | | | 4 | 3 | 2 | |
+/- | 1 | 3 | 1 | 1 | 2 | 1 | 1 | | 4 |
1+ | 2 | 1 | 3 | 1 | 2 | | 1 | 2 | |
2+ | 3 | 1 | 1 | 2 | | | | 1 | 1 |
3+ | 4 | | | 1 | 1 | | | | |
No. of animals | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
a) The unit of urobilinogen is ehrlich unit/dL, *: Represents a significant difference at p<0.05 level compared with the vehicle control, **: GLU: Glucose, BIL: Bilirubin, KET: Ketone body, SG: Specific gravity, PRO: Protein, URO: Urobilinogen, NIT: Nitrite, OB: Occult blood, LEU: Leukocyte, %: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day), High -dose group (G4: 5,000 mg/10 mL/day)